“Although randomized clinical trials are normally used to approve therapeutics, the federal government has not required COVID ...

This year's headlines on COVID-19 featured new research on COVID-related mortality, post-acute sequelae of infection, vaccine ...

The trial will be conducted in the Democratic Republic of the Congo in partnership with Emergent BioSolutions.

Aligos Therapeutics, Inc. ( (ALGS) ) has released its Q3 earnings. Here is a breakdown of the information Aligos Therapeutics, Inc. presented ...

Robert W. Baird analyst Brian Skorney maintained a Buy rating on Soleno Therapeutics (SLNO – Research Report) on November 6 and set a ...

A critical challenge during the early COVID-19 pandemic was determining whether a patient would survive the infection or die ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

Despite a dip in revenue, Arcturus Therapeutics Holdings Inc (ARCT) celebrates a successful vaccine launch in Japan and ...

Bashan declined to reveal how much the company owed creditors, but in its bankruptcy filing in U.S. Bankruptcy Court in ...

Coya Therapeutics, Inc. (Nasdaq: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance regu ...

Good afternoon and welcome to Arcturus Therapeutics quarterly financial update and pipeline ... our self-amplifying mRNA COVID-19 vaccine. We're thrilled about our recent commercial launch of KOSTAIVE ...